Literature DB >> 14523447

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

Camilla Englund1, Christina E Lorén, Caroline Grabbe, Gaurav K Varshney, Fabienne Deleuil, Bengt Hallberg, Ruth H Palmer.   

Abstract

The Drosophila melanogaster gene Anaplastic lymphoma kinase (Alk) is homologous to mammalian Alk, a member of the Alk/Ltk family of receptor tyrosine kinases (RTKs). We have previously shown that the Drosophila Alk RTK is crucial for visceral mesoderm development during early embryogenesis. Notably, observed Alk visceral mesoderm defects are highly reminiscent of the phenotype reported for the secreted molecule Jelly belly (Jeb). Here we show that Drosophila Alk is the receptor for Jeb in the developing visceral mesoderm, and that Jeb binding stimulates an Alk-driven, extracellular signal-regulated kinase-mediated signalling pathway, which results in the expression of the downstream gene duf (also known as kirre)--needed for muscle fusion. This new signal transduction pathway drives specification of the muscle founder cells, and the regulation of Duf expression by the Drosophila Alk RTK explains the visceral-mesoderm-specific muscle fusion defects observed in both Alk and jeb mutant animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523447     DOI: 10.1038/nature01950

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  62 in total

Review 1.  Emerging importance of ALK in neuroblastoma.

Authors:  Anna M Azarova; Gargi Gautam; Rani E George
Journal:  Semin Cancer Biol       Date:  2011-09-16       Impact factor: 15.707

2.  HLH54F is required for the specification and migration of longitudinal gut muscle founders from the caudal mesoderm of Drosophila.

Authors:  Afshan Ismat; Christoph Schaub; Ingolf Reim; Katharina Kirchner; Dorothea Schultheis; Manfred Frasch
Journal:  Development       Date:  2010-09       Impact factor: 6.868

3.  Genetic control of fusion pore expansion in the epidermis of Caenorhabditis elegans.

Authors:  Tamar Gattegno; Aditya Mittal; Clari Valansi; Ken C Q Nguyen; David H Hall; Leonid V Chernomordik; Benjamin Podbilewicz
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

4.  Anterograde Jelly belly ligand to Alk receptor signaling at developing synapses is regulated by Mind the gap.

Authors:  Jeffrey Rohrbough; Kendal Broadie
Journal:  Development       Date:  2010-10       Impact factor: 6.868

Review 5.  Pathobiology of ALK+ anaplastic large-cell lymphoma.

Authors:  Hesham M Amin; Raymond Lai
Journal:  Blood       Date:  2007-05-22       Impact factor: 22.113

6.  Identification of receptor-tyrosine-kinase-signaling target genes reveals receptor-specific activities and pathway branchpoints during Drosophila development.

Authors:  John R Leatherbarrow; Marc S Halfon
Journal:  Genetics       Date:  2009-02-02       Impact factor: 4.562

7.  C. elegans anaplastic lymphoma kinase ortholog SCD-2 controls dauer formation by modulating TGF-beta signaling.

Authors:  David J Reiner; Michael Ailion; James H Thomas; Barbara J Meyer
Journal:  Curr Biol       Date:  2008-08-05       Impact factor: 10.834

8.  The Drosophila Receptor Tyrosine Kinase Alk Constrains Long-Term Memory Formation.

Authors:  Jean Y Gouzi; Mikela Bouraimi; Ilianna G Roussou; Anastasios Moressis; Efthimios M C Skoulakis
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

9.  Org-1 is required for the diversification of circular visceral muscle founder cells and normal midgut morphogenesis.

Authors:  Christoph Schaub; Manfred Frasch
Journal:  Dev Biol       Date:  2013-02-01       Impact factor: 3.582

10.  p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.

Authors:  Chiara Ambrogio; Claudia Voena; Andrea D Manazza; Roberto Piva; Ludovica Riera; Laura Barberis; Carlotta Costa; Guido Tarone; Paola Defilippi; Emilio Hirsch; Elisabetta Boeri Erba; Shabaz Mohammed; Ole N Jensen; Giorgio Palestro; Giorgio Inghirami; Roberto Chiarle
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.